Teva- Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products.
Current Price
$35.73
-0.78%GoodMoat Value
$21.98
38.5% overvaluedTeva- Pharmaceutical Industries Ltd (TEVA) Stock Chart
TEVA Interactive Stock Chart
Interactive stock chart for Teva- Pharmaceutical Industries Ltd (TEVA) with candlestick and line chart views. Analyze price action across multiple timeframes: 5 days, 1 week, 1 month, 3 months, 6 months, 1 year, 5 years, and full history.
Current price: $35.73. 52-week high: $36.34. 52-week low: $15.38. 50-day moving average: $31.45. 200-day moving average: $26.37.
Technical analysis indicators include Volume, SMA 20, SMA 50, SMA 200, EMA 20, and RSI. Toggle between candlestick and line chart styles. Overlay multiple moving averages to identify support and resistance levels, trend direction, and momentum signals for TEVA. Use the chart alongside GoodMoat's fundamental analysis tools for a complete picture of Teva- Pharmaceutical Industries Ltd's investment potential.